Dr. Mark L Lemire is a Encinitas, California based male chiropractor who is specialized as General Chiropractor. Active license number of Dr. Mark L Lemire as General Chiropractor is 18244 in California. Dr. Mark L Lemire is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Mark L Lemire speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
DC
Gender:
Male
Practice Address:
119 N El Camino Real, Suite F, Encinitas, California, 92024-5397
Phone:
760-484-0114
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1316297997
NPI Enumeration Date:
11 Sep, 2012
NPI Last Update On:
11 Sep, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark L Lemire are as mentioned below.
License Number
Specialization
State
Status
18244
Chiropractor
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
119 N El Camino Real, Suite F Encinitas, California
Zip:
92024-5397
Phone Number:
760-484-0114
Fax Number:
--
Patients can reach Dr. Mark L Lemire at 119 N El Camino Real, Suite F, Encinitas, California or can call to book an appointment on 760-484-0114. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.